Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
